Nolan CM - Search Results

1

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.

Nolan CM, Williams DL, Cave MD, Eisenach KD, el-Hajj H, Hooton TM, Thompson RL, Goldberg SV. Nolan CM, et al. Am J Respir Crit Care Med. 1995 Sep;152(3):1067-71. doi: 10.1164/ajrccm.152.3.7663785. Am J Respir Crit Care Med. 1995. PMID: 7663785

2

Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus.

Tabet SR, Goldbaum GM, Hooton TM, Eisenach KD, Cave MD, Nolan CM. Tabet SR, et al. Among authors: nolan cm. J Infect Dis. 1994 Jan;169(1):189-92. doi: 10.1093/infdis/169.1.189. J Infect Dis. 1994. PMID: 7903974

3

Directly observed isoniazid preventive therapy for released jail inmates.

Nolan CM, Roll L, Goldberg SV, Elarth AM. Nolan CM, et al. Am J Respir Crit Care Med. 1997 Feb;155(2):583-6. doi: 10.1164/ajrccm.155.2.9032198. Am J Respir Crit Care Med. 1997. PMID: 9032198

4

Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.

Goldberg SV, Duchin JS, Shields T, Nolan CM. Goldberg SV, et al. Among authors: nolan cm. Am J Respir Crit Care Med. 1999 Aug;160(2):508-12. doi: 10.1164/ajrccm.160.2.9808039. Am J Respir Crit Care Med. 1999. PMID: 10430721

5

Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.

Nolan CM, Goldberg SV. Nolan CM, et al. Int J Tuberc Lung Dis. 2002 Nov;6(11):952-8. Int J Tuberc Lung Dis. 2002. PMID: 12475140

6

Characterization of rifampin-resistance in pathogenic mycobacteria.

Williams DL, Waguespack C, Eisenach K, Crawford JT, Portaels F, Salfinger M, Nolan CM, Abe C, Sticht-Groh V, Gillis TP. Williams DL, et al. Among authors: nolan cm. Antimicrob Agents Chemother. 1994 Oct;38(10):2380-6. doi: 10.1128/AAC.38.10.2380. Antimicrob Agents Chemother. 1994. PMID: 7840574 Free PMC article.

7

New developments in tuberculosis and HIV infection: an opportunity for prevention.

Curtis JR, Hooton TM, Nolan CM. Curtis JR, et al. Among authors: nolan cm. J Gen Intern Med. 1994 May;9(5):286-94. doi: 10.1007/BF02599660. J Gen Intern Med. 1994. PMID: 8046533 Review.

8

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.

Nolan CM, Goldberg SV, Buskin SE. Nolan CM, et al. JAMA. 1999 Mar 17;281(11):1014-8. doi: 10.1001/jama.281.11.1014. JAMA. 1999. PMID: 10086436

9

Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru.

Campos PE, Suarez PG, Sanchez J, Zavala D, Arevalo J, Ticona E, Nolan CM, Hooton TM, Holmes KK. Campos PE, et al. Among authors: nolan cm. Emerg Infect Dis. 2003 Dec;9(12):1571-8. doi: 10.3201/eid0912.020731. Emerg Infect Dis. 2003. PMID: 14720398 Free PMC article.

10

Tuberculosis prevention among foreign-born persons in Seattle--King County, Washington.

Wells CD, Zuber PL, Nolan CM, Binkin NJ, Goldberg SV. Wells CD, et al. Among authors: nolan cm. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):573-7. doi: 10.1164/ajrccm.156.2.9611101. Am J Respir Crit Care Med. 1997. PMID: 9279242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters